Ubs Asset Management Americas Inc Prothena Corp Public LTD CO Transaction History

Ubs Asset Management Americas Inc

  • $345 Billion
  • Q2 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 43,075 shares of PRTA stock, worth $863,223. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,075
Previous 375,165 88.52%
Holding current value
$863,223
Previous $9.29 Million 90.43%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$19.54 - $26.15 $6.49 Million - $8.68 Million
-332,090 Reduced 88.52%
43,075 $889,000
Q1 2024

May 15, 2024
BUY
$24.75 - $40.66 $2.06 Million - $3.39 Million
83,298 Added 28.54%
375,165 $9.29 Million
Q4 2023

Feb 14, 2024
BUY
$32.31 - $52.32 $834,244 - $1.35 Million
25,820 Added 9.71%
291,867 $10.6 Million
Q3 2023

Nov 13, 2023
BUY
$47.3 - $70.6 $1.88 Million - $2.81 Million
39,845 Added 17.61%
266,047 $12.8 Million
Q1 2023

May 15, 2023
SELL
$46.97 - $58.27 $101,737 - $126,212
-2,166 Reduced 0.95%
226,202 $11 Million
Q4 2022

Feb 14, 2023
SELL
$52.05 - $65.0 $762,116 - $951,730
-14,642 Reduced 6.03%
228,368 $13.8 Million
Q2 2022

Aug 12, 2022
SELL
$22.73 - $39.98 $385,591 - $678,220
-16,964 Reduced 6.53%
243,010 $6.6 Million
Q4 2021

Feb 14, 2022
SELL
$42.11 - $73.26 $835,841 - $1.45 Million
-19,849 Reduced 7.09%
259,974 $12.8 Million
Q3 2021

Nov 15, 2021
SELL
$48.2 - $78.89 $5.9 Million - $9.65 Million
-122,345 Reduced 30.42%
279,823 $19.9 Million
Q2 2021

Aug 16, 2021
BUY
$21.63 - $57.65 $1.07 Million - $2.86 Million
49,641 Added 14.08%
402,168 $20.7 Million
Q1 2021

May 14, 2021
BUY
$11.0 - $28.24 $3.48 Million - $8.94 Million
316,420 Added 876.34%
352,527 $8.86 Million
Q2 2020

Aug 14, 2020
SELL
$9.56 - $12.51 $59,826 - $78,287
-6,258 Reduced 14.77%
36,107 $377,000
Q1 2020

May 15, 2020
SELL
$7.54 - $15.77 $83,301 - $174,226
-11,048 Reduced 20.68%
42,365 $453,000
Q4 2019

Feb 14, 2020
BUY
$7.48 - $17.01 $143,212 - $325,673
19,146 Added 55.87%
53,413 $845,000
Q3 2019

Nov 14, 2019
BUY
$6.89 - $10.45 $23,784 - $36,073
3,452 Added 11.2%
34,267 $268,000
Q2 2019

Aug 15, 2019
BUY
$8.85 - $12.49 $30,930 - $43,652
3,495 Added 12.79%
30,815 $0
Q1 2019

May 14, 2019
BUY
$10.32 - $14.49 $127,142 - $178,516
12,320 Added 82.13%
27,320 $0
Q2 2018

Aug 14, 2018
BUY
$10.99 - $44.21 $164,322 - $661,027
14,952 Added 31150.0%
15,000 $0
Q3 2017

Nov 13, 2017
BUY
$53.83 - $67.75 $2,583 - $3,252
48
48 $0

Others Institutions Holding PRTA

# of Institutions
182
Shares Held
42.7M
Call Options Held
77.7K
Put Options Held
92.7K
View Full List

About PROTHENA CORP PUBLIC LTD CO

PRTA Quotes by TradingView
  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $940M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email